Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT
Authors:
Open Access
- 1 November 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (48) , e12900
Abstract
Background: The risk of local recurrence (LR) continues to threat patients with rectal cancer after surgery or chemoradiotherapy. The main reason is that there is frequently extensive scarring and reactive changes after radiotherapy and resection. Thus, the diagnosis of LR can be challenging. There are different imaging modalities that have been used in the follow-up of rectal cancer, including computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and positron emission tomography-computed tomography (PET-CT) in clinical practice. Methods: We will systematically search PubMed, EMBASE, the Cochrane Library, and Chinese Biomedical Literature Database for diagnostic trials using CT, MRI, PET, and PET-CT to detect LR of rectal cancer in April, 2018. Two review authors will independently screen titles and abstracts for relevance, assess full texts for inclusion, and carry out data extraction and methodological quality assessment using the QUADAS-2 tool. We will use bivariate meta-analysis to estimate summary sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of CT, MRI, PET, and PET-CT, as well as different sequences of MRI. For each index test, estimates of sensitivity and specificity from each study will be plotted in summary receive operating curve space and forest plots will be constructed for visual examination of variation in test accuracy. We will perform meta-analyses using the hierarchical summary receiver-operating characteristic model to produce summary estimates of sensitivity and specificity. Then, head-to-head and indirect comparison meta-analyses will be carried out. Discussion: This review will help determine the diagnostic accuracy of CT, MRI, PET, and PET-CT for the diagnosis of patients with LR of rectal cancer. Ethics and dissemination: Ethics approval and patient consent are not required, as this study is a systematic review. PROSPERO registration number: CRD42018104918.Keywords
This publication has 28 references indexed in Scilit:
- The nuts and bolts of PROSPERO: an international prospective register of systematic reviewsSystematic Reviews, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinomaCochrane Database of Systematic Reviews, 2007
- Routine Follow-up by Magnetic Resonance Imaging Does Not Improve Detection of Resectable Local Recurrences From Colorectal CancerAnnals of Surgery, 2006
- Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice GuidelineJournal of Clinical Oncology, 2005
- The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJournal of Clinical Epidemiology, 2005
- Local recurrence of colorectal cancer: The problem, mechanisms, management and adjuvant therapyBritish Journal of Surgery, 1994
- LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTIONThe Lancet, 1986